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Abstract: The demand of bone graft materials has been increasing. Among various origins of bone
graft materials, natural coral composed of up to 99% calcium carbonate was chosen and converted
into hydroxyapatite (HA); silicon was then substituted into the HA. Then, the Si-HA was mixed with
β-tricalcium phosphate (TCP) in the ratios 100:0 (S100T0), 70:30 (S70T30), 60:40 (S60T40), and 50:50
(S50T50). The materials were implanted for four and eight weeks in a rat calvarial bone defect model
(8 mm). The MBCPTM (HA:β-TCP = 60:40, Biomatalante, Vigneux de Bretagne, France) was used as
a control. After euthanasia, the bone tissue was analyzed by making histological slides. From the
results, S60T40 showed the fastest bone regeneration in four weeks (p < 0.05). In addition, S60T40,
S50T50, and MBCPTM showed significant new bone formation in eight weeks (p < 0.05). In conclusion,
Si-HA/TCP showed potential as a bone graft material.
Keywords: silicon-substituted coral hydroxyapatite; beta-tricalcium phosphate; bone graft material;
bone regeneration; rat calvarial bone defect model
1. Introduction
Bone graft materials are in high demand for the replacement of bone tissues due to accidents,
diseases, or other implantation needs. Various bone graft materials have been introduced, and an
autograft or allograft was regarded as the gold standard. However, there were many limitations,
such as bone quantity, risks of immune responses, and disease transmission [1]. Therefore,
chemically-synthesized biomaterials, such as hydroxyapatite (HA) and β-tricalcium phosphate (TCP),
have become preferred bone graft materials of choice [2]. HA has achieved significant application in a
range of medical and dental applications. However, due to its slow rate of degradation, components
with faster degradation rates were added; among them, β-TCP has been used as one of the main
components of bone graft materials [3]. In many products, the degradation rate is controlled by
changing the ratio of HA to β-TCP, and so many products have a HA:β-TCP ratio of 60:40 or 70:30.
HA can be obtained from biological and natural sources, such as coral and seashells [4]. In this
study, we used raw sea coral to synthesize HA. Coral is pure calcium carbonate (with up to 99%) and
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little amino acid and oligo elements. It is easily obtained in large quantities from nature and the risk of
infection is lower than with an allograft [5]. The coral genus Goniopora was used as raw material here.
It has a porous structure and the pores are interconnected similar to bone. We have synthesized this
into HA in previous studies [6,7].
Silicon is one of the most abundant elements on earth and it is an important element in the body.
It has been detected in cartilage and other connective tissues [8]. Si is known as a key element in the
early stages of the biomineralization process and it was reported as an HA inducer [9–13]. From the
previous studies, we choose the amount of silicon and we substituted approximately 1 wt % of silicon
in coral HA [6].
Thus, using a synthesized Si-HA mixed with various ratio of β-TCP, we evaluate its bioactivity
in an animal model. The objective of this study was to evaluate osteoconductivity of new bone graft
material groups in a bone-defect model.
2. Results
2.1. Radiological Findings after Four Weeks and Eight Weeks
The X-ray results are shown in Figure 1. The granule materials were placed in the defect area
and it was marked with circle. In addition, the surgical sites of all groups, except the control, were
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in blank  control groups at  four and eight weeks. Although all groups  showed  that  the materials 
remained unabsorbed,  the number particles had decreased after eight weeks compared with  four 
weeks. In eight weeks, there were embedded bone graft particles in new bones (S70T30 and S60T40). 
Figure 1. X-ray pictures (four weeks and eight weeks); Cont is the blank control group.
2.2. Histological Findings at Four Weeks and Eight Weeks
The histological slides after four and eight weeks are shown in Figure 2. The original and new
bone was stained with blue and an osteoid was in red (arrows). There were only connective tissues in
blank control groups at four and eight weeks. Although all groups showed that the materials remained
unabsorbed, the number particles had decreased after eight weeks compared with four weeks. In eight
weeks, there were embedded bone graft particles in new bones (S70T30 and S60T40).
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and  dental  applications. HA,  generally,  are  based  on  a  chemical  reaction  between  calcium  and 
phosphorous salts and it can also be obtained from biological sources such as coral and sea shells. 
One of  the advantages of HA derived  from natural  sources  is  that  it already  contains  the minor 
elements,  which  can  have  beneficial  effects  on  HA  properties  [4].  This  study  was  designed  to 
evaluate new bone graft materials containing naturally‐derived Si‐HA and β‐TCP mixture in a bone 
defect model. In the previous study, the natural coral was used as scaffold with its interconnected 
pores  throughout  its  structure  because  it  resembles  the  microstructure  of  trabecular  bones.   
In addition, the coral met the requirements of bone graft materials in quantity and purity. It is made 
up of 99% calcium carbonate and, through the thermal process, the CaCO3 transformed to HA and 
any amino acids, oligo elements, and other  impurities were eliminated  [7]. We used  the  coral  in 
Figure 2. Histological slides with Masson’s Trichrome staining (four weeks and eight weeks).
2.3. Quantified Results of Histological Slides (Four Weeks and Eight Weeks)
The new bone density is quantified in Figure 3. In four weeks (Figure 3A), there was no bone
formation in the blank control (Cont). The S60T40 was significantly higher than others (p < 0.05),
however, there were no significant differences among the MBCP, S100T0, S70T30, and S50T50. In eight
weeks (Figure 3B), there was new bone formation in the blank control (Cont). The S60T40, S50T50, and
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and, through the thermal process, the CaCO3 transformed to HA and any amino acids, oligo elements,
and other impurities were eliminated [7]. We used the coral in granule form, and during the process the
macroscale structure was collapsed. However, the micro and interconnected structures were reserved.
In bone remodeling various factors such as, mineral elements, cells, and extracellular membranes,
and many growth factors are required. In addition, the micro-environment has been an important
factor to start tissue regeneration at the early stage of bone repair. In this study, we focused on silicon,
which has been known as an accelerator in bone mineralization. During the process of converting coral
into HA, we substituted Si ions into the HA structure. In a previous study, Carlisle et al. reported that
Si played an integral role during the mineralization process and it has been reported as a fundamental
element in collagen [9]. Porter et al. had conducted an implantation test, and after six and 12 weeks
they reported that although both pure HA and Si-HA showed good results, organized collagen fibrils
were found in the Si-HA implants after six weeks. However, these structures were found only after
12 weeks in pure HA implants [14].
The HA:β-TCP ratio of 60:40 has been designated the gold standard due to its ideal dissolution
rate. In the previous study of HA and TCP graft at 60:40 ratio, they reported that 26%–40% of new
bone was formed in bone defect model, and 27% of material remained after 4–9 months [15]. Although
little is known about the effect of Si on cells, there was histological evidence of new bone formation in
the biological response to an implant [13] and also we could confirmed in the S60T40 group after four
weeks (Figures 2 and 3A), and we suggested that this may be osteoconductive.
From the Si-substituted HA, we expected the released Si to affect new bone formation and, indeed,
the S60T40 (Si-HA/β-TCP) showed significantly higher bone formation than MBCPTM (HA/β-TCP)
in four weeks. The dissolution rate of HA in vivo was influenced by how the Si incorporated into the
HA lattice [14]. The weight percentage of Si in HA may increase the solubility of the material [16,17].
Poter et al. also reported that Si increases the dissolution rate of HA. Dissolution was observed to
be the highest with 1.5 wt % Si-HA, followed by 0.8 wt % Si-HA, and pure HA. It was found to be
particularly prevalent at grain boundaries and triple-junctions and these observations may help to
explain the mechanism of dissolution in Si-HA compared to pure HA [14]. From the result, if the
in vivo bioactivity is related to this dissolution-reprecipitation mechanism, the results of this study,
which had having used materials of approximately 1 wt % HA were as expected [6]. In this study, we
compared the new bone density between S60T40 (Si-HA:β-TCP = 6:4) and MBCPTM (HA:β-TCP = 6:4),
S60T40 showed significantly higher values in four weeks.
The critical-size defect in rat calvaria has been regarded as the most desirable model because its
poor blood supply and membranous structure of the bone precludes any natural healing. The defect
should be the smallest diameter intraosseous wound possible without natural bone healing. We made
an 8 mm defect, and the blank control confirmed that there was no bone regeneration at the defect
site [18–22].
The histological slides provide qualitative evidence that the defect areas were not filled completely.
In Figures 2 and 3A,B, the granules still remained in the area from 4 to 8 weeks. Similar results had
been reported after 10 weeks in a previous study [23]. In addition, the speed of new bone formation
had slowed by eight weeks. It seems that during the first four weeks, the materials can reach bodily
fluids. However, after collagen and new bone formed, the materials were incorporated into the new
bone, and the possibility of contact with bodily fluids had decreased. After four weeks, there was little
bone formation and the materials maintained their original morphology. On the other hand, although
the materials still remained in the defect site, more particles had dissolved by eight weeks. According
to the blank control, the bone healing started from the margins of the defect, and connective fibrous
tissues came into the defect before bone formation. However, in the eight week experiment groups
such as S60T40 and S70T30, there were embedded bone graft particles in new bone at the margin of
the defect.
From the X-ray results, quantitative densitometric analysis for new bone formation could not be
analyzed properly due to the material’s radiopaque nature, so we could not check noticeable bone
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regeneration results. We just confirmed that the materials stayed in the defect hole and the bone graft
materials had tightened under the periosteal membrane even after eight weeks.
In conclusion, we successfully made Si-substituted coral HA from natural coral and with various
ratios to β-TCP. We confirmed S60T40 implants had significantly more new bone formation in four
weeks and eight weeks. It was clear that Si plays an important role in bone mineralization. It is,
therefore, of future interest to investigate the other effects of S60T40 on the process of osteogenesis.
4. Experimental Section
4.1. Preparation of Si-Substituted Coral HA and β-TCP Mixture
4.1.1. Preparation and Characterization of Si-Substituted Coral HA
The natural Goniopora coral (CaCO3, sGulf of Mannar, Indonesia) with interconnected pore sizes
of 300–500 µm was purchased. Briefly, the purchased corals were immersed in NaOCl (12%–13%)
for 24 h and then sonicated in distilled water to remove organic matter and impurities. The coral
was cut into blocks and placed in a hydrothermal reactor with silicon tetra acetate-acetone solution
(Sigma-Aldrich, St. Louis, MO, USA). After reacting for 24 h at 200 ˝C, the CaCO3 was converted
into HA. Then, it was immersed in tetraortho silicate solution (TEOS, Sigma-Aldrich, St. Louis, MO,
USA) and reacted at 60 ˝C for 48 h to synthesize silicon-substituted HA. Approximately 1 wt % of
silicon was substituted into the HA structure. Si-HA was synthesized and characterized as described
in reference [6].
4.1.2. Synthesis of β-TCP
We synthesized β-tricalcium phosphate (β-TCP) in this study. Briefly, calcium nitrate tetrahydrate
solution (Ca(NO3)2¨4H2O, Junsei, Chuo-ku, Japan) and potassium dihydrogen phosphate solution
(KH2PO4, Junsei, Chuo-ku, Japan) were mixed under stirring and the mixed solution was filtered.
The filtered powder was dried and mixed with dispersant to make slurry. The slurry was absorbed
into a polyurethane sponge (PU sponge, 80 ppi) and dried for 24 h. The dried sponge was sintered at
1100 ˝C until the PU sponge burnt away. Finally, the sintered β-TCP block was milled into granules,
sized 100–600 µm.
4.1.3. Si-Substituted Coral HA and β-TCP Mixture
To make the final composition of experimental bone graft materials, the Si-substituted coral HA
and TCP granules were mixed homogeneously at ratios of 100:0, 70:30, 60:40, and 50:50.
4.2. Materials for Animal Experiments
To evaluate bone healing ability, we conducted animal experiments with each material in Table 1.
The MBCPTM (Biomatlante, Vigneux de Bretagne, France) was used as the control product. We used
various Si-substituted coral HA and TCP mixtures as experimental groups, which were described in
Section 4.1.
Table 1. Experimental groups used in this study.
Groups Label Pure HA Si-Substituted Coral HA β-TCP
Blank control group Cont - - -
Control product group MBCP 60 - 40
Experimental groups
S100T0 - 100 0
S70T30 - 70 30
S60T40 - 60 40
S50T50 - 50 50
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4.3. In Vivo Determination of Bone Regeneration of Bone Defect Model
All animal procedures were approved by the Institutional Animal Care and Use Committee
(IACUC), Yonsei University Biomedical research institute (No. 06-236). Sixty specific-pathogen-free
(SPF) Sprague-Dawley Rats weighing between 250 and 300 g underwent operation. Before surgery,
the rats were monitored during seven days of stabilization. The rats were divided into two groups
(four weeks and eight weeks) with six animals in each group. For the blank control and product
control, we used three rats each. Briefly, the instruments were sterilized by autoclave and the materials
were prepared. General anesthesia was induced by intramuscular injection (IM) with an anesthesia
cocktail solution (0.1 mL/10 g) of a mixture of Zoletil (Zoletil 50 Vibrac, Carros cedex, France) and
Xylazine (Rompun, Bayer Korea, Seoul, Korea). The calvaria fur was clipped and surfaces were
sterilized by iodine. Local anesthesia of 2% lidocaine and 1:100,000 epinephrine (Lignospan Standard,
Septodont, New Castle, DE, USA) was injected. The incision was drawn sagittal through the skin and
the periosteum at the midline of the calvaria. Then, the flap was reflected and an 8 mm bone defect was
created by a trephine bur under sterile saline irrigation. After puncturing the calvaria bone, implant
materials were placed carefully in the hole. Then, the defect was covered by the periosteum and
stitched with absorbed silk (Vicryl 4-0, Ethicon, Norderstedt, Germany) and the skin was stitched with
black silk. The rats were euthanized after four or eight weeks. Under anesthesia, the perfusion fixation
was performed with 4% paraformaldehyde. The calvaria were removed and we took a periapical
X-rays. The fixed tissues were subjected to X-ray imaging at 65 ˘ 5 kVp for 0.1 s. In this case, a distance
between an X-ray tube and the tissues was set to 10 cm. The photographed X-ray film was developed
and cone defect regions were then observed on the developed X-rays image. For the histological slides,
the tissues were decalcified with 0.5 M Ethylenediaminetetraacetic acid (EDTA, Welgene, Korea) for
three months and the bone tissues were made into histological slides (7 µm) and stained with Massons’
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5. Conclusions 
In  this  study,  the  Si‐substituted  coral HA  and  β‐TCP mixture  in  the  ratio  of  60:40  showed 
superior osteogenic properties to pure HA in the rat calvarial bone defect model. 
Figure 4. The surgical process (8 mm defect criteria).
4.4. Histological Evaluation
To evaluate new bone formation, all histological slides were photographed at ˆ400 magnification.
First, the defect area (AD) in the histological slide was outlined using Photoshop (Adobe Photoshop
7.0, San Jose, CA, USA) and calculated. The areas of new bone were selected and calculated (AN). The
new bone density was calculated as AN/AD [24].
4.5. Statistics
The histological results were processed using the SPSS Statistics 20 (SPSS Inc., Chicago, IL,
USA). The one-way Analysis of variance for variance analysis with Tukey's multiple comparison was
performed and the p values under 0.05 were considered statistically significant.
5. cl si s
In this study, the Si-substituted coral HA and β-TCP mixture in th ratio of 60:40 showed superior
osteogenic prop rties to ure HA in the rat calvarial bone defect mo l.
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